Published • loading... • Updated
Novo Nordisk Wins Case Against Counterfeit Drugs in the US
Summary by BT
4 Articles
4 Articles
BT+2 Reposted by 2 other sources
A US appeals court has ruled that the FDA followed procedure when it removed weight loss drugs from the shortage list.
·Borås, Sweden
Read Full Article
Novo Nordisk and Eli Lilly, together with the US Food and Drug Administration, have won a case in a federal appeals court that the two pharmaceutical companies' mega-selling drugs for diabetes and obesity are no longer in short supply, Bloomberg News reports.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
